Jin Medical International earnings were $1.8M for the trailing 12 months ending Mar 31, 2025, with -50% growth year over year. The latest ZJYL earnings report on Mar 31, 2025 announced Q1 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, ZJYL reported annual earnings of $3.7M, with 27.7% growth. The next ZJYL earnings date is Jan 23, 2026.
ZJYL past earnings growth
How has ZJYL's earnings growth performed historically?
Jin Medical International Earnings Reports & History FAQ
What were Jin Medical International's earnings last quarter?
Jin Medical International (NASDAQ: ZJYL) reported Q1 2025 earnings per share (EPS) of N/A, up N/A year over year. Total ZJYL earnings for the quarter were N/A. In the same quarter last year, Jin Medical International's earnings per share (EPS) was N/A.
When does Jin Medical International report earnings?
The next ZJYL earnings call is Invalid Date. Add ZJYL to your watchlist to be reminded of Jin Medical International's next earnings date.
What was ZJYL's earnings growth in the past year?
As of Jin Medical International's earnings date in Q4 2025, Jin Medical International's earnings has grown -50% year over year. This is 60.57 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 10.57%. ZJYL earnings in the past year totalled $1.79 million.
Is Jin Medical International profitable or losing money?
As of the last Jin Medical International earnings report, Jin Medical International is currently profitable. Jin Medical International's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $1.79 million, a 38.31% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.